We are in the midst of an exciting time of rapid advances and innovation for Stereotactic Body Radiation Therapy (SBRT) across multiple disease sites, particularly for thoracic malignancies. Over the past decades, the role of SBRT for lung cancer continues to evolve and grow. This focused issue aims at reviewing these evolving issues and bringing insights to researchers in the field of thoracic radiation oncology.
